Analyst Update: NVIDIA Corporation, Mobileye NV, and SCYNEXIS Inc

Analysts are weighing in on NVIDIA Corporation (NVDA), Mobileye NV (MBLY), and SCYNEXIS Inc (SCYX)

Oct 20, 2016 at 3:18 PM
facebook X logo linkedin


Analysts are weighing in on chipmaker NVIDIA Corporation (NASDAQ:NVDA), self-driving tech expert Mobileye NV (NYSE:MBLY), and biotech issue SCYNEXIS Inc (NASDAQ:SCYX). Here's a quick roundup of today's brokerage notes on NVDA, MBLY, and SCYX.

  • NVDA is 2.1% higher at $67.84 after Mizuho Securities reiterated its "buy" rating on the stock, noting that NVIDIA Corporation stands to profit from its contract with Tesla Motors Inc (NASDAQ:TSLA), after the electric carmaker last night announced all of its vehicles will now be produced with complete "self-driving" technology -- with NVIDIA earning the right to be a pivotal chip provider (subscription required). This upbeat outlook is shared by the majority of analysts, with 14 out of 24 maintaining a "buy" or better opinion. And that's no surprise, considering NVDA has more than doubled on the charts year-to-date, thanks in part to support from the 50-day moving average since February.
  • An analyst at Barclays is taking a different view of Tesla's latest announcement, calling it "overly hyped" and throwing his chips in with MBLY -- with which Tesla recently split. Specifically, the firm suggested a pair trade, banking on TSLA falling and expecting Mobileye NV to outperform. It seems reasonable that MBLY could be on the verge of an upturn, as the stock's 14-day Relative Strength Index (RSI) is sitting in oversold territory, at 28. But traders aren't on board yet -- nearly 17% of MBLY's available float is wrapped up in short interest, representing almost two weeks' of trading, at the stock's typical daily pace. At last check, MBLY was up 2.7% at $38.31.

  • H.C. Wainwright has initiated coverage on SCYX with a "buy" rating and $14 price target -- representing a 270% premium over current levels, and a region the shares haven't seen since January 2015. What's more, the brokerage firm described the company as a "dapper fungus zapper." The stock is up 3.8% at $3.78 as a result, but still sits on a 42% year-over-year loss. In fact, the shares skidded as far south as $1.74 just a few months ago. On the plus side, it looks like SCYNEXIS Inc has found an ally in the form of its 40-day moving average. And the brokerage bunch as a whole has high expectations for the stock, since every analyst tracking SCYX recommends buying the shares. 
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI